IVBT (Innovation1 Biotech) Accounts Payable: $0.36 Mil (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech Accounts Payable?

Innovation1 Biotech IVBT 12 Accounts Payable is $0.36 Mil as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

Innovation1 Biotech's Accounts Payable for the quarter that ended in Feb. 2024 was $0.36 Mil.

Innovation1 Biotech's quarterly Accounts Payable increased from Aug. 2023 ($0.35 Mil) to Nov. 2023 ($0.36 Mil) but then declined from Nov. 2023 ($0.36 Mil) to Feb. 2024 ($0.36 Mil).

Innovation1 Biotech's annual Accounts Payable increased from Aug. 2021 ($0.04 Mil) to Aug. 2022 ($0.11 Mil) and increased from Aug. 2022 ($0.11 Mil) to Aug. 2023 ($0.35 Mil).

Innovation1 Biotech Accounts Payable Related Terms

Innovation1 Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech Accounts Payable Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 0.05 0.44 0.04 0.11 0.35

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.31 0.35 0.36 0.36
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.36 Mil mean?
Innovation1 Biotech (IVBT) has a Accounts Payable of $0.36 Mil as of Feb. 2024. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's Accounts Payable too high?
Innovation1 Biotech's current Accounts Payable is $0.36 Mil. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's Accounts Payable compare to NVIV and PXMD?
Innovation1 Biotech's Accounts Payable of $0.36 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Diversified Financial Services company?
A good Accounts Payable depends on the Diversified Financial Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current Accounts Payable is $0.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current Accounts Payable of $0.36 Mil. The current Accounts Payable is $0.36 Mil. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current Accounts Payable is $0.36 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price